FDA sets new PDUFA date for Capricor's Deramiocel therapy
Go back to FDA sets new PDUFA date for Capricor's Deramiocel therapy| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 26.44 -3.96 (13.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.40 | 52 Week High | $5.40 | |||
| Open | $27.20 | 52 Week Low | $1.88 | |||
| Day High | $27.40 | P/E | N/A | |||
| Day Low | $25.63 | EPS | $0.00 | |||
| Volume | 5,487,984 | |||||
